{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:11:28Z","timestamp":1781525488851,"version":"3.54.1"},"reference-count":58,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Foods"],"abstract":"<jats:p>Hyperglycemia due to uncontrolled glucose regulation is widely known as cause of diabetes, non-alcoholic fatty liver disease (NAFLD), and other complications. NAFLD refers to a condition in which fat is excessively accumulated, whether inflamed or not, and has caused serious medical problems in recent years. The aim of this study was to explore the antihyperglycemia effects of Limosilactobacillus fermentum MG4295 (L. fermentum MG4295) in high-fat diet (HFD)-induced in vivo. We demonstrated the suitability of L. fermentum MG4295 as a probiotic by observing its stability, survivability, and proliferation under simulated gastrointestinal conditions, and safety, antibiotic susceptibility, hemolysis, and enzyme activity. The potential antihyperglycemic activity of L. fermentum MG4295 was investigated in an HFD and sugar-water-induced mouse model. Administration of this strain for 12 weeks showed an improved trend in glucose tolerance, insulin, alanine amino transferase, total cholesterol, low-density lipoprotein cholesterol, and glucagon-like peptide-1. Histopathological analysis revealed that L. fermentum MG4295 significantly reduced the histopathological scores of hepatic steatosis, inflammation, and hepatocellular hypertrophy in liver tissues and lipid content in adipose tissues. Administration of L. fermentum MG4295 upregulated IRS-1, AKT, and GLUT4 and downregulated G6Pc and PEPCK expression in liver and\/or muscle tissues. Our results suggest that L. fermentum MG4295 can improve hyperglycemia. Furthermore, it can be used as a dietary functional supplement to manage blood glucose.<\/jats:p>","DOI":"10.3390\/foods11020231","type":"journal-article","created":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T20:44:00Z","timestamp":1642365840000},"page":"231","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Limosilactobacillus fermentum MG4295 Improves Hyperglycemia in High-Fat Diet-Induced Mice"],"prefix":"10.3390","volume":"11","author":[{"given":"Ji Eun","family":"Kim","sequence":"first","affiliation":[{"name":"MEDIOGEN, Co., Ltd., Biovalley 1-ro, Jecheon-si 27159, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3622-7392","authenticated-orcid":false,"given":"Ji Yeon","family":"Lee","sequence":"additional","affiliation":[{"name":"MEDIOGEN, Co., Ltd., Biovalley 1-ro, Jecheon-si 27159, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6466-8550","authenticated-orcid":false,"given":"Chang-Ho","family":"Kang","sequence":"additional","affiliation":[{"name":"MEDIOGEN, Co., Ltd., Biovalley 1-ro, Jecheon-si 27159, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1177\/193229680900300604","article-title":"Hyperglycemia in critical illness: A review","volume":"3","author":"Brealey","year":"2009","journal-title":"J. Diabetes Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: A systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Wang","year":"2016","journal-title":"Lancet"},{"key":"ref_4","first-page":"1000167","article-title":"Late stage complications of diabetes and insulin resistance","volume":"2","author":"Soumya","year":"2011","journal-title":"J. Diabetes Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1210\/jc.2007-0298","article-title":"The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis","volume":"92","author":"Pittas","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Chyau, C.-C., Wang, H.-F., Zhang, W.-J., Chen, C.-C., Huang, S.-H., Chang, C.-C., and Peng, R.Y. (2020). Antrodan alleviates high-fat and high-fructose diet-induced fatty liver disease in C57BL\/6 mice model via AMPK\/Sirt1\/SREBP-1c\/PPAR\u03b3 pathway. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21010360"},{"key":"ref_7","first-page":"247","article-title":"Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus","volume":"47","author":"Brickl","year":"1997","journal-title":"Arzneim.-Forsch."},{"key":"ref_8","first-page":"70","article-title":"What every dentist should know about metformin, diabetes, and cancer","volume":"63","author":"Frykenberg","year":"2015","journal-title":"Gen. Dent."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2049-3258-72-6","article-title":"The high-cost, type 2 diabetes mellitus patient: An analysis of managed care administrative data","volume":"72","author":"Meyers","year":"2014","journal-title":"Arch. Public Health"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"154001","DOI":"10.1016\/j.metabol.2019.154001","article-title":"Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!","volume":"101","author":"Ranjbar","year":"2019","journal-title":"Metabolism"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature12198","article-title":"Gut metagenome in European women with normal, impaired and diabetic glucose control","volume":"498","author":"Karlsson","year":"2013","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ji, Y., Yin, Y., Li, Z., and Zhang, W. (2019). Gut microbiota-derived components and metabolites in the progression of non-alcoholic fatty liver disease (NAFLD). Nutrients, 11.","DOI":"10.3390\/nu11081712"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1039\/D0FO02879G","article-title":"Lactobacillus rhamnosus FJSYC4-1 and Lactobacillus reuteri FGSZY33L6 alleviate metabolic syndrome via gut microbiota regulation","volume":"12","author":"Zheng","year":"2021","journal-title":"Food Funct."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13568-020-01066-8","article-title":"Extrinsic factors influencing gut microbes, the immediate consequences and restoring eubiosis","volume":"10","author":"Bajinka","year":"2020","journal-title":"AMB Express"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet\u2013induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4166\/kjg.2019.74.6.314","article-title":"Role of gut microbiota in type 2 diabetes mellitus and its complications: Novel insights and potential intervention strategies","volume":"74","author":"Woldeamlak","year":"2019","journal-title":"Korean J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12967-020-02213-2","article-title":"Effects of probiotics on type II diabetes mellitus: A meta-analysis","volume":"18","author":"Tao","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Tanase, D.M., Gosav, E.M., Neculae, E., Costea, C.F., Ciocoiu, M., Hurjui, L.L., Tarniceriu, C.C., Maranduca, M.A., Lacatusu, C.M., and Floria, M. (2020). Role of gut microbiota on onset and progression of microvascular complications of type 2 diabetes (T2DM). Nutrients, 12.","DOI":"10.3390\/nu12123719"},{"key":"ref_21","first-page":"1935","article-title":"Role and effective therapeutic target of gut microbiota in NAFLD\/NASH","volume":"18","author":"Liu","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_22","first-page":"1419","article-title":"Potential antidiabetic activities of probiotic strains, L. acidophilus and L. bulgaricus against fructose-fed hyperglycemic rats","volume":"10","author":"Sohag","year":"2019","journal-title":"Food Sci. Nutr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"16372","DOI":"10.1038\/s41598-018-34678-z","article-title":"\u03b2-Glucuronidases of opportunistic bacteria are the major contributors to xenobiotic-induced toxicity in the gut","volume":"8","author":"Dashnyam","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1039\/C8FO00081F","article-title":"Administration of Lactobacillus paracasei ameliorates type 2 diabetes in mice","volume":"9","author":"Dang","year":"2018","journal-title":"Food Funct."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12602-017-9299-1","article-title":"The effects of synbiotic supplementation on glucose metabolism and lipid profiles in patients with diabetes: A systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Tabrizi","year":"2018","journal-title":"Probiotics Antimicrob. Proteins."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.medmal.2013.10.002","article-title":"Probiotics, gut microbiota and health","volume":"44","author":"Butel","year":"2014","journal-title":"Med. Mal. Infect."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1007\/s00284-021-02588-5","article-title":"In Vitro Antidiabetic, Antioxidant Activity, and Probiotic Activities of Lactiplantibacillus plantarum and Lacticaseibacillus paracasei Strains","volume":"78","author":"Won","year":"2021","journal-title":"Curr. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijfoodmicro.2004.08.020","article-title":"A dynamic model that simulates the human upper gastrointestinal tract for the study of probiotics","volume":"99","author":"Mainville","year":"2005","journal-title":"Int. J. Food Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1046\/j.1365-2672.2003.01915.x","article-title":"Adhesion and aggregation ability of probiotic strain Lactobacillus acidophilus M92","volume":"94","author":"Kos","year":"2003","journal-title":"J. Appl. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Rychen, G., Aquilina, G., Azimonti, G., Bampidis, V., Bastos, M.d.L., Bories, G., Chesson, A., Cocconcelli, P.S., and Flachowsky, G. (2018). Guidance on the characterisation of microorganisms used as feed additives or as production organisms. EFSA J., 16, e05206.","DOI":"10.2903\/j.efsa.2018.5206"},{"key":"ref_31","unstructured":"Isenberg, H.D. (1992). Clinical Microbiology Procedures Handbook, ASM."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12257-019-0406-x","article-title":"Evaluating the Cryoprotective Encapsulation of the Lactic Acid Bacteria in Simulated Gastrointestinal Conditions","volume":"25","author":"Nguyen","year":"2020","journal-title":"Biotechnol. Bioprocess Eng."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00394-016-1317-7","article-title":"Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL\/6J mice","volume":"57","author":"Balakumar","year":"2018","journal-title":"Eur. J. Nutr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.foodchem.2013.05.121","article-title":"Regulation of lipid and glucose homeostasis by mango tree leaf extract is mediated by AMPK and PI3K\/AKT signaling pathways","volume":"141","author":"Zhang","year":"2013","journal-title":"Food Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e04467","DOI":"10.1016\/j.heliyon.2020.e04467","article-title":"Global analysis of clinical trials with probiotics","volume":"6","author":"Dronkers","year":"2020","journal-title":"Heliyon"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1007\/s00253-019-09978-7","article-title":"Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health","volume":"103","author":"Rastall","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.5352\/JLS.2012.22.9.1194","article-title":"Probiotic potential of Pediococcus pentosaceus BCNU 9070","volume":"22","author":"Shin","year":"2012","journal-title":"J. Life Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1472-765X.1998.t01-1-00449.x","article-title":"Autoaggregation and adhesion ability in a Bifidobacterium suis strain","volume":"27","author":"Busetto","year":"1998","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/1750-3841.13608","article-title":"Physiological changes of surface membrane in Lactobacillus with prebiotics","volume":"82","author":"Pan","year":"2017","journal-title":"J. Food Sci."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Krausova, G., Hyrslova, I., and Hynstova, I. (2019). In vitro evaluation of adhesion capacity, hydrophobicity, and auto-aggregation of newly isolated potential probiotic strains. Fermentation, 5.","DOI":"10.3390\/fermentation5040100"},{"key":"ref_41","first-page":"84","article-title":"Aggregation and adhesion abilities of 18 lactic acid bacteria strains isolated from traditional fermented food","volume":"3","author":"Li","year":"2015","journal-title":"Int. J. Agric. Policy Res."},{"key":"ref_42","unstructured":"FAO, and WHO (2002). Guidelines for the Evaluation of Probiotics in Food, Report of a Joint FAO\/WHO Working Group on Drafting Guideline for the Evaluation of Probiotic in Food, WHO."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kang, M.-S., Yeu, J.-E., and Hong, S.-P. (2019). Safety evaluation of oral care probiotics Weissella cibaria CMU and CMS1 by phenotypic and genotypic analysis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112693"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijfoodmicro.2005.03.008","article-title":"Antibiotic resistance in food lactic acid bacteria\u2014A review","volume":"105","author":"Mathur","year":"2005","journal-title":"Int. J. Food Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nut.2006.09.002","article-title":"Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats","volume":"23","author":"Yadav","year":"2007","journal-title":"Nutrition"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.nut.2011.08.013","article-title":"Probiotic yogurt improves antioxidant status in type 2 diabetic patients","volume":"28","author":"Ejtahed","year":"2012","journal-title":"Nutrition"},{"key":"ref_47","first-page":"5843","article-title":"Lactobacillus plantarum NA136 improves the non-alcoholic fatty liver disease by modulating the AMPK\/Nrf2 pathway","volume":"103","author":"Zhao","year":"2019","journal-title":"Appl. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2337\/db14-1176","article-title":"Ghrelin is a novel regulator of GLP-1 secretion","volume":"64","author":"Gagnon","year":"2015","journal-title":"Diabetes"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s001250051165","article-title":"Is glucagon-like peptide 1 an incretin hormone?","volume":"42","author":"Nauck","year":"1999","journal-title":"Diabetologia"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"E418","DOI":"10.1210\/jc.2013-3644","article-title":"Glucose-dependent insulinotropic polypeptide: Effects on insulin and glucagon secretion in humans","volume":"99","author":"Christensen","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"25088","DOI":"10.1074\/jbc.M113.452516","article-title":"Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion","volume":"288","author":"Yadav","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"109914","DOI":"10.1016\/j.biopha.2020.109914","article-title":"Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db\/db mice","volume":"125","author":"Wang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.diabet.2017.05.009","article-title":"Effect of GLP-1 receptor agonist on gastrointestinal tract motility and residue rates as evaluated by capsule endoscopy","volume":"43","author":"Nakatani","year":"2017","journal-title":"Diabetes Metab. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1191-e315","DOI":"10.1111\/j.1365-2982.2010.01554.x","article-title":"Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis","volume":"22","author":"Edholm","year":"2010","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6108575","DOI":"10.1155\/2020\/6108575","article-title":"Lactobacillus rhamnosus Reduces Blood Glucose Level through Downregulation of Gluconeogenesis Gene Expression in Streptozotocin-Induced Diabetic Rats","volume":"2020","author":"Farida","year":"2020","journal-title":"Int. J. Food Sci."}],"container-title":["Foods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2304-8158\/11\/2\/231\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:39:40Z","timestamp":1760362780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2304-8158\/11\/2\/231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["foods11020231"],"URL":"https:\/\/doi.org\/10.3390\/foods11020231","relation":{},"ISSN":["2304-8158"],"issn-type":[{"value":"2304-8158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,15]]}}}